[Answered] Long-term use of sleep medications among the elderly can lead to _____

This topic contains a solution. Click here to go to the answer

Author Question: Long-term use of sleep medications among the elderly can lead to ______. a. cardiovascular ... (Read 25 times)

azncindy619

Hero Member
Posts: 562

on: Jun 22, 2018

Long-term use of sleep medications among the elderly can lead to ______.

a. cardiovascular problems c. hypertension
b. insomnia d. dependence

Question 2

The most common sleep problem faced by the elderly is ______.

a. insomnia c. sleep apnea
b. narcolepsy d. night terrors

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Pamela.irrgang@yahoo.com

Sr. Member
Posts: 323

Reply #1 on: Jun 22, 2018

Answer to Question 1

D

Answer to Question 2

A

azncindy619

Member
Posts: 562

Reply 2 on: Jun 22, 2018

TYSM

Bigfoot1984

Member
Posts: 321

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.